Skip to main content

Closed

GRI: GRI Bio, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-100.0% / yr

Operating margin0.0%

ROIC-103.1%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage0.0×

Current ratio14.21×

GRI Bio, Inc.

GRINASDAQ·USD·Closed

GRI Bio, Inc.

GRINASDAQ·USD·Closed

$1.38

−2.13%

$1.38

−$0.03 (2.13%)

52W Range

0thpctl

Volume

0.35×avg

Mkt Cap

123968USD

P/E

-0.0TTM

Div Yield

–ann

52W Range

0thpctl

Volume

0.35×avg

Market Cap

123968USD

P/E Ratio

-0.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings